XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Equity (Narrative) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Apr. 18, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Increase (decrease) in stock-based compensation from change in management's estimate       $ 2,776    
Unrecognized compensation cost   $ 99,899   99,899    
Total intrinsic value of options exercised       10,019    
Aggregate intrinsic value of options exercisable   $ 67,512   $ 67,512    
Market value of Company's common stock (in USD per share)   $ 59.62   $ 59.62    
Weighted average exercise price per share (in USD per share)   $ 53.17   $ 53.17    
Total options outstanding (in shares)   17,509   17,509    
Total options exercisable (in shares)   8,325   8,325    
Dividends declared per common share (in USD per share) $ 0.43 $ 0.43 $ 0.40 $ 0.43 $ 0.40  
Cash dividends declared   $ 57,177 $ 54,378 $ 57,177 $ 54,378  
Common Stock Buyback            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares purchased and retired (in shares)       2,651    
Company purchased, cost       $ 155,869    
Additional authorized amount           $ 250,000
Remaining stock repurchase authorization amount           $ 186,983,274
2014 Plan | Tranche One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting rate       50.00%    
2014 Plan | Tranche Two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting rate       50.00%    
Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award waiting period       2 years    
Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award waiting period       4 years